Nanjing Well Pharmaceutical Co Ltd (603351) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.15x

Nanjing Well Pharmaceutical Co Ltd (603351) has a Cash Flow Reinvestment Rate of 0.15x as of September 2025, reinvesting CN¥10.29 Million (capex CN¥10.29 Million ) from operating cash flow of CN¥69.51 Million. Check cash flow quality index of Nanjing Well Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.15x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥10.29 Million
Capex + Investments

Operating Cash Flow

CN¥69.51 Million
CNY

Capital Expenditures

CN¥10.29 Million
CNY

Nanjing Well Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Nanjing Well Pharmaceutical Co Ltd across 10 annual periods. Explore debt repayment capacity of Nanjing Well Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Nanjing Well Pharmaceutical Co Ltd (2014–2024)

Year-by-year capital reinvestment analysis for Nanjing Well Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Nanjing Well Pharmaceutical Co Ltd.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 0.31x CN¥69.78 Million CN¥221.79 Million CN¥51.46 Million ▼ -51.7%
2023 0.65x CN¥78.30 Million CN¥120.24 Million CN¥73.07 Million ▼ -70.3%
2022 2.19x CN¥238.63 Million CN¥108.99 Million CN¥233.90 Million ▼ -49.1%
2020 4.30x CN¥401.31 Million CN¥93.30 Million CN¥282.44 Million ▲ +12.3%
2019 3.83x CN¥496.88 Million CN¥129.69 Million CN¥120.62 Million ▼ -46.1%
2018 7.11x CN¥453.22 Million CN¥63.76 Million CN¥76.95 Million ▲ +15.2%
2017 6.17x CN¥439.62 Million CN¥71.27 Million CN¥63.35 Million ▲ +1017.9%
2016 0.55x CN¥70.73 Million CN¥128.18 Million CN¥69.31 Million ▼ -41.8%
2015 0.95x CN¥76.92 Million CN¥81.14 Million CN¥76.92 Million ▼ -20.1%
2014 1.19x CN¥88.54 Million CN¥74.62 Million CN¥88.54 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow